Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
Recruiting · NCT05865301 · Registry updated 2026-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Not stated | 2026-06-04 | NCT05865301 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Stanford University | 620 |
| The Pediatric Oncology Experimental Therapeutics Investigators' Consortium | 2 |
22 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.